Extracellular Vesicles from Leishmania-Infected Macrophages Confer an Anti-infection Cytokine-Production Profile to Naïve Macrophages

PLoS Neglected Tropical Diseases

Volumn 8, Issue 9, 2014, Pages

  Cronemberger Andrade, André ^a   Aragão França, Luciana ^a   de Araujo, Cintia Figueiredo ^a   Rocha, Viviane Junqueira ^a   Borges Silva, Mariana da Cruz ^a   Figueiras, Cláudio P ^a   Oliveira, Pablo R ^a   de Freitas, Luiz A R ^a   Veras, Patrícia S T ^a   Pontes de Carvalho, Lain ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW CELL; CELL VACUOLE; CELL VIABILITY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; MEMBRANE VESICLE; MOUSE; NONHUMAN; PHENOTYPE; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; EXOSOME; IMMUNOLOGY; PARASITOLOGY;

ANIMALS; CELLS, CULTURED; EXTRACELLULAR VESICLES; LEISHMANIA; LEISHMANIASIS; MACROPHAGES; MICE; MICE, INBRED BALB C;

EID: 84907587248     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003161     Document Type: Article

References (61)

1. Desjeux P, (2001) The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 95: 239–243.
2. Desjeux P, (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305–318 doi:10.1016/j.cimid.2004.03.004
3. Herwaldt BL, (1999) Leishmaniasis. Lancet 354: 1191–1199 doi:10.1016/S0140-6736(98)10178-2
4. Alexander J, Satoskar a R, Russell DG, (1999) Leishmania species: models of intracellular parasitism. J Cell Sci 112 Pt 18: 2993–3002.
5. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, et al. (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 177: 1797–1802.
6. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK, (1993) Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177: 1505–1509.
7. Trinchieri G, (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13: 251–276 doi:10.1146/annurev.iy.13.040195.001343
8. Carrera L, Gazzinelli RT, Badolato R, Hieny S, Muller W, et al. (1996) Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 183: 515–526.
9. O'Neill HC, Quah BJC, (2008) Exosomes secreted by bacterially infected macrophages are proinflammatory. Sci Signal 1: pe8 doi:10.1126/stke.16pe8
10. Théry C, Ostrowski M, Segura E, (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9: 581–593 doi:10.1038/nri2567
11. Johansson SM, Admyre C, Scheynius A, Gabrielsson S, (2008) Different types of in vitro generated human monocyte-derived dendritic cells release exosomes with distinct phenotypes. Immunology 123: 491–499 doi:10.1111/j.1365-2567.2007.02714.x
12. Bhatnagar S, Shinagawa K, Castellino FJ, Schorey JS, (2007) Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 110: 3234–3244 doi:10.1182/blood-2007-03-079152
13. Bhatnagar S, Shinagawa K, Castellino FJ, Schorey JS, (2007) Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 110: 3234–3244 doi:10.1182/blood-2007-03-079152
14. Schorey JS, Bhatnagar S, (2008) Exosome function: from tumor immunology to pathogen biology. Traffic 9: 871–881 doi:10.1111/j.1600-0854.2008.00734.x
15. Giri PK, Kruh Na, Dobos KM, Schorey JS, (2010) Proteomic analysis identifies highly antigenic proteins in exosomes from M. tuberculosis-infected and culture filtrate protein-treated macrophages. Proteomics 10: 3190–3202 doi:10.1002/pmic.200900840
16. Beauvillain C, Ruiz S, Guiton R, Bout D, Dimier-Poisson I, (2007) A vaccine based on exosomes secreted by a dendritic cell line confers protection against T. gondii infection in syngeneic and allogeneic mice. Microbes Infect 9: 1614–1622 doi:10.1016/j.micinf.2007.07.002
17. Chaput N, Schartz NEC, André F, Taïeb J, Novault S, et al. (2004) Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J Immunol 172: 2137–2146.
18. Del Cacho E, Gallego M, Lee SH, Lillehoj HS, Quilez J, et al. (2011) Induction of protective immunity against Eimeria tenella infection using antigen-loaded dendritic cells (DC) and DC-derived exosomes. Vaccine 29: 3818–3825 doi:10.1016/j.vaccine.2011.03.022
19. Schnitzer JK, Berzel S, Fajardo-Moser M, Remer Ka, Moll H, (2010) Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major. Vaccine 28: 5785–5793 doi:10.1016/j.vaccine.2010.06.077
20. Théry C, Boussac M, Véron P, Ricciardi-Castagnoli P, Raposo G, et al. (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 166: 7309–7318.
21. Meckes DG, Raab-Traub N, (2011) Microvesicles and viral infection. J Virol 85: 12844–12854 doi:10.1128/JVI.05853-11
22. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, et al. (1996) B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183: 1161–1172.
23. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, et al. (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 4: 594–600 doi:10.1038
24. Théry C, Zitvogel L, Amigorena S, (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2: 569–579 doi:10.1038/nri855
25. Admyre C, Johansson SM, Paulie S, Gabrielsson S, (2006) Direct exosome stimulation of peripheral human T cells detected by ELISPOT. Eur J Immunol 36: 1772–1781 doi:10.1002/eji.200535615
26. Wolfers J, Lozier A, Raposo G, Regnault A, Théry C, et al. (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7: 297–303 doi:10.1038/85438
27. Bhatnagar S, Schorey JS, (2007) Exosomes released from infected macrophages contain Mycobacterium avium glycopeptidolipids and are proinflammatory. J Biol Chem 282: 25779–25789 doi:10.1074/jbc.M702277200
28. Walker JD, Maier CL, Pober JS, (2009) Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes. J Immunol 182: 1548–1559.
29. Silverman JM, Clos J, Horakova E, Wang AY, Wiesgigl M, et al. (2010) Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells. J Immunol 185: 5011–5022 doi:10.4049/jimmunol.1000541
30. Zwaal RF, Schroit aJ, (1997) Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89: 1121–1132.
31. Cocucci E, Racchetti G, Meldolesi J, (2009) Shedding microvesicles: artefacts no more. Trends Cell Biol 19: 43–51 doi:10.1016/j.tcb.2008.11.003
32. Walters SB, Kieckbusch J, Nagalingam G, Swain A, Latham SL, et al. (2013) Microparticles from mycobacteria-infected macrophages promote inflammation and cellular migration. J Immunol 190: 669–677 doi:10.4049/jimmunol.1201856
33. Zhang Y, Zhang R, Zhang H, Liu J, Yang Z, et al. (2012) Microparticles released by Listeria monocytogenes-infected macrophages are required for dendritic cell-elicited protective immunity. Cell Mol Immunol 9: 489–496 doi:10.1038/cmi.2012.33
34. Thomas LM, Salter RD, (2010) Activation of macrophages by P2X7-induced microvesicles from myeloid cells is mediated by phospholipids and is partially dependent on TLR4. J Immunol 185: 3740–3749 doi:10.4049/jimmunol.1001231
35. Beyer C, Pisetsky DS, (2010) The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol 6: 21–29 doi:10.1038/nrrheum.2009.229
36. Savill J, Dransfield I, Gregory C, Haslett C, (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2: 965–975 doi:10.1038/nri957
37. Lutz MB, Kukutsch N, Ogilvie a L, Rössner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77–92.
38. Tung JW, Heydari K, Tirouvanziam R, Sahaf B, Parks DR, et al. (2007) Modern flow cytometry: a practical approach. Clin Lab Med 27: 453–68, v doi:10.1016/j.cll.2007.05.001
39. Duarte TA, Noronha-Dutra AA, Nery JS, Ribeiro SB, Pitanga TN, et al. (2012) Mycobacterium tuberculosis-induced neutrophil ectosomes decrease macrophage activation. Tuberculosis (Edinb) 92: 218–225 doi:10.1016/j.tube.2012.02.007
40. Bacellar O, M CE, (2005) Imunopatogênese da Leishmaniose Visceral. Gaz Médica da Bahia 75: 24–34.
41. Carvalho EM, (2012) Parasite, vectors and reservoirs as determinants of tegumentary leishmaniasis. Rev Soc Bras Med Trop 45: 423–424.
42. Hatzigeorgiou DE, He S, Sobel J, Grabstein KH, Hafner A, et al. (1993) IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages. J Immunol 151: 3682–3692.
43. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, et al. (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415–1420.
44. Meimaridou E, Jacobson J, Seddon AM, Noronha-Dutra AA, Robertson WG, et al. (2005) Crystal and microparticle effects on MDCK cell superoxide production: oxalate-specific mitochondrial membrane potential changes. Free Radic Biol Med 38: 1553–1564 doi:10.1016/j.freeradbiomed.2005.02.020
45. Obregon C, Rothen-Rutishauser B, Gitahi SK, Gehr P, Nicod LP, (2006) Exovesicles from human activated dendritic cells fuse with resting dendritic cells, allowing them to present alloantigens. Am J Pathol 169: 2127–2136 doi:10.2353/ajpath.2006.060453
46. Faria MS, Reis FCG, Azevedo-Pereira RL, Morrison LS, Mottram JC, et al. (2011) Leishmania inhibitor of serine peptidase 2 prevents TLR4 activation by neutrophil elastase promoting parasite survival in murine macrophages. J Immunol 186: 411–422 doi:10.4049/jimmunol.1002175
47. Ruhland A, Kima PE, (2009) Activation of PI3K/Akt signaling has a dominant negative effect on IL-12 production by macrophages infected with Leishmania amazonensis promastigotes. Exp Parasitol 122: 28–36 doi:10.1016/j.exppara.2008.12.010
48. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK, (1993) Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177: 1505–1509.
49. Lima-Junior DS, Costa DL, Carregaro V, Cunha LD, Silva ALN, et al. (2013) Inflammasome-derived IL-1β production induces nitric oxide-mediated resistance to Leishmania. Nat Med 19: 909–915 doi:10.1038/nm.3221
50. Liew FY, Li Y, Millott S, (1990) Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine. Immunology 71: 556–559.
51. Liew FY, Parkinson C, Millott S, Severn A, Carrier M, (1990) Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis. Immunology 69: 570–573.
52. Souza MA, Castro MCAB, Oliveira AP, Almeida AF, Reis LC, et al. (2012) American tegumentary leishmaniasis: cytokines and nitric oxide in active disease and after clinical cure, with or without chemotherapy. Scand J Immunol 76: 175–180 doi:10.1111/j.1365-3083.2012.02717.x
53. De Assis Souza M, de Castro MCAB, de Oliveira AP, de Almeida AF, de Almeida TM, et al. (2013) Cytokines and NO in American tegumentary leishmaniasis patients: profiles in active disease, after therapy and in self-healed individuals. Microb Pathog 57: 27–32 doi:10.1016/j.micpath.2013.02.004
54. Hassani K, Olivier M, (2013) Immunomodulatory impact of leishmania-induced macrophage exosomes: a comparative proteomic and functional analysis. PLoS Negl Trop Dis 7: e2185.
55. Silverman JM, Reiner NE, (2011) Leishmania exosomes deliver preemptive strikes to create an environment permissive for early infection. Front Cell Infect Microbiol 1: 26 doi:10.3389/fcimb.2011.00026
56. Pankoui Mfonkeu JB, Gouado I, Fotso Kuaté H, Zambou O, Amvam Zollo PH, et al. (2010) Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria. PLoS One 5: e13415 doi:10.1371/journal.pone.0013415
57. Sancho D, Reis e Sousa C, (2013) Sensing of cell death by myeloid C-type lectin receptors. Curr Opin Immunol 25: 46–52 doi:10.1016/j.coi.2012.12.007
58. Dubaniewicz A, (2013) Microbial and human heat shock proteins as “danger signals” in sarcoidosis. Hum Immunol doi:10.1016/j.humimm.2013.08.275
59. Edye ME, Lopez-Castejon G, Allan SM, Brough D, (2013) Acidosis Drives Damage-associated Molecular Pattern (DAMP)-induced Interleukin-1 Secretion via a Caspase-1-independent Pathway. J Biol Chem 288: 30485–30494 doi:10.1074/jbc.M113.478941
60. Moore KJ, Matlashewski G, (1994) Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J Immunol 152: 2930–2937.
61. Srivastav S, Basu Ball W, Gupta P, Giri J, Ukil A, et al. (2014) Leishmania donovani prevents oxidative burst-mediated apoptosis of host macrophages through selective induction of suppressors of cytokine signaling (SOCS) proteins. J Biol Chem 289: 1092–1105 doi:10.1074/jbc.M113.496323